LivingGLP1
Study S000655

Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes

Registration

Registration
NCT02140983
Acronym
LGT
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
TRIPLE
Status
COMPLETED
Enrollment
41
Start
2013-08
Primary completion
2017-02
Lead sponsor
Stanford University
Conditions
Insulin Resistance; Dementia
Interventions
DRUG:Liraglutide; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • Cognitive Outcomes [Change from Baseline to 3 months]
  • OGTT [Change from Baseline to 3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.